© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Emotional red flags in AD, eg, sleep loss, isolation, hopelessness, often go unseen. Quick screening questions can surface the real burden individuals carry.
Identifying the mental health burden of atopic dermatitis (AD) requires moving beyond questions about skin symptoms to explore the broader impact on patients' lives. Simple screening questions integrated into routine visits can uncover hidden suffering and guide treatment decisions. "A lot of times, as clinicians, we focus on objective skin scores, like achieving a certain EASI score or an IGA score, but the reality is, the skin doesn't always tell the whole story.
"This disease has a multidimensional burden that goes far beyond what we can see or [even] what the patient can see," dermatologist Mona Shahriari, MD, assistant clinical professor of dermatology at the Yale School of Medicine, said in a recent interview with Patient Care.©8
"I routinely ask questions like, 'Having eczema can sometimes make people feel down or anxious—do you ever feel that way?' or 'Is there anything you're not doing because of your eczema?' These kinds of questions give us critical insight into the lived experience of the disease and help redefine what adequate control really means," shd added.8
Beyond assessing skin clearance and itch severity, consider incorporating these questions into your AD visits. These are based on Patient Care interviews with Shahriari and other leading dermatologists in 2025 as well as research in the current AD literature:
Sleep and Functioning
Emotional Impact
Social Functioning
For Adolescents Specifically
These questions can be woven naturally into the visit and don't require formal screening instruments, though validated tools like the Patient Health Questionnaire-9 (PHQ-9; depression) or General Anxiety Disorder-7 (GAD-7; anxiety) can be used when concerns arise.
Certain clinical presentations should immediately raise concern about significant psychological burden3-5,8:
"When a patient with AD walks into your clinic, it might feel like just another rash on the schedule. But for them, it could be the reason they don’t leave the house" Shariari stressed. "It could be the reason they don’t fall in love. It could be the reason they stop dreaming. Taking the time to ask the right questions, to understand the full burden of disease, and to start effective treatment—those things can genuinely transform lives."3 She emphasized that severe psychosocial impairment warrants the same clinical urgency as severe skin disease.3